Murdoch University Research Repository

Welcome to the Murdoch University Research Repository

The Murdoch University Research Repository is an open access digital collection of research
created by Murdoch University staff, researchers and postgraduate students.

Learn more

Publications: Needham, Merrilee

Stats for Needham, Merrilee
Export as [feed] RSS
Group by: Item Type | Year
Jump to: 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005
Number of items: 101.

2021

Amato, A.A., Hanna, M.G., Machado, P.M., Badrising, U.A., Chinoy, H., Benveniste, O., Karanam, A.K., Wu, M., Tankó, L.B., Schubert-Tennigkeit, A.A., Papanicolaou, D.A., Lloyd, T.E., Needham, M., Liang, C., Reardon, K.A., de Visser, M., Ascherman, D.P., Barohn, R.J., Dimachkie, M.M., Miller, J.A.L., Kissel, J.T., Oskarsson, B., Joyce, N.C., Van den Bergh, P., Baets, J., De Bleecker, J.L., Karam, C., David, W.S., Mirabella, M., Nations, S.P., Jung, H.H., Pegoraro, E., Maggi, L., Rodolico, C., Filosto, M., Shaibani, A.I., Sivakumar, K., Goyal, N.A., Mori-Yoshimura, M., Yamashita, S., Suzuki, N., Aoki, M., Katsuno, M., Morihata, H., Murata, K., Nodera, H., Nishino, I., Romano, C.D., Williams, V.S.L., Vissing, J. and Zhang Auberson, L. (2021) Efficacy and safety of Bimagrumab in sporadic inclusion body myositis. Neurology, 96 (12). e1595-e1607.

Pugh, J.D., McCoy, K., Needham, M., Jiang, L., Giles, M., McKinnon, E. and Heine, K. (2021) Evaluation of an Australian neurological nurse‐led model of postdischarge care. Health & Social Care in the Community . Early View.

Ashton, C., Paramalingam, S., Stevenson, B., Brusch, A. and Needham, M. (2021) Idiopathic inflammatory myopathies: A review. Internal Medicine Journal, 51 (6). pp. 845-852.

Nabais, M.F., Laws, S.M., Lin, T., Vallerga, C.L., Armstrong, N.J.ORCID: 0000-0002-4477-293X, Blair, I.P., Kwok, J.B., Mather, K.A., Mellick, G.D., Sachdev, P.S., Wallace, L., Henders, A.K., Zwamborn, R.A.J., Hop, P.J., Lunnon, K., Pishva, E., Roubroeks, J.A.Y., Soininen, H., Tsolaki, M., Mecocci, P., Lovestone, S., Kłoszewska, I., Vellas, B., Furlong, S., Garton, F.C., Henderson, R.D., Mathers, S., McCombe, P.A., Needham, M., Ngo, S.T., Nicholson, G., Pamphlett, R., Rowe, D.B., Steyn, F.J., Williams, K.L., Anderson, T.J., Bentley, S.R., Dalrymple-Alford, J., Fowder, J., Gratten, J., Halliday, G., Hickie, I.B., Kennedy, M., Lewis, S.J.G., Montgomery, G.W., Pearson, J., Pitcher, T.L., Silburn, P., Zhang, F., Visscher, P.M., Yang, J., Stevenson, A.J., Hillary, R.F., Marioni, R.E., Harris, S.E., Deary, I.J., Jones, A.R., Shatunov, A., Iacoangeli, A., van Rheenen, W., van den Berg, L.H., Shaw, P.J., Shaw, C.E., Morrison, K.E., Al-Chalabi, A., Veldink, J.H., Hannon, E., Mill, J., Wray, N.R. and McRae, A.F. (2021) Meta-analysis of genome-wide DNA methylation identifies shared associations across neurodegenerative disorders. Genome Biology, 22 (1). Art. 90.

Vucic, S., Wray, N., Henders, A., Henderson, R.D., Talman, P., Mathers, S., Bellgard, M., Aoun, S., Birks, C., Thomas, G., Hansen, C., Thomas, G., Hogden, A., Needham, M., Schultz, D., Soulis, T., Sheean, B., Milne, J., Rowe, D., Zoing, M. and Kiernan, M.C. (2021) MiNDAUS partnership: A roadmap for the cure and management of motor Neurone disease. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration .

Paramalingam, S., Needham, M., Raymond, W., Mastaglia, F., Lightowler, D., Morin, N., Counsel, P. and Keen, H.I. (2021) Muscle shear wave elastography, conventional B mode and power doppler ultrasonography in healthy adults and patients with autoimmune inflammatory myopathies: A pilot cross-sectional study. BMC Musculoskeletal Disorders, 22 (1). Art. 537.

Theunissen, F., Anderton, R.S., Mastaglia, F.L., Flynn, L.L., Winter, S.J., James, I., Bedlack, R., Hodgetts, S., Fletcher, S., Wilton, S.D., Laing, N.G., MacShane, M., Needham, M., Saunders, A., MacKay-Sim, A., Melamed, Z., Ravits, J., Cleveland, D.W. and Akkari, P.A. (2021) Novel STMN2 variant linked to amyotrophic lateral sclerosis risk and clinical phenotype. Frontiers in Aging Neuroscience, 13 . Art. 658226.

Restuadi, R., Garton, F.C., Benyamin, B., Lin, T., Williams, K.L., Vinkhuyzen, A., van Rheenen, W., Zhu, Z., Laing, N.G., Mather, K.A., Sachdev, P.S., Ngo, S.T., Steyn, F.J., Wallace, L., Henders, A.K., Visscher, P.M., Needham, M., Mathers, S., Nicholson, G., Rowe, D.B., Henderson, R.D., McCombe, P.A., Pamphlett, R., Blair, I.P., Wray, N.R. and McRae, A.F. (2021) Polygenic risk score analysis for amyotrophic lateral sclerosis leveraging cognitive performance, educational attainment and schizophrenia. European Journal of Human Genetics .

Vucic, S., Henderson, R.D., Mathers, S., Needham, M., Schultz, D. and Kiernan, M.C. (2021) Safety and efficacy of dimethyl fumarate in ALS: randomised controlled study. Annals of Clinical and Translational Neurology .

2020

Ashton, C., Banham, N. and Needham, M. (2020) Acute spontaneous spinal cord infarction: Utilisation of hyperbaric oxygen treatment, cerebrospinal fluid drainage and pentoxifylline. Diving and Hyperbaric Medicine Journal, 50 (4). pp. 325-331.

Esfandiary, T., Park, J.K., Alexanderson, H., Regardt, M., Needham, M., de Groot, I., Sarver, C., Lundberg, I.E., de Visser, M., Song, Y.W., DiRenzo, D., Bingham, C.O., Christopher-Stine, L. and Mecoli, C.A. (2020) Assessing the content validity of patient-reported outcome measures in adult myositis: A report from the OMERACT myositis working group. Seminars in Arthritis and Rheumatism, 50 (5). pp. 943-948.

Mathew, V., Wencel, M., Habib, A.A., Goyal, N.A., Needham, M. and Mozaffar, T. (2020) Attitudes toward non-interventional observational studies in US and Australian patients with sporadic inclusion body myositis. Journal of Clinical Neuromuscular Disease, 21 (4). pp. 246-247.

Mohannak, N., Pattison, G., Radich, B., Hird, K., Godecke, E., Mastaglia, F. and Needham, M. (2020) Exploring the efficacy of the expiratory muscle strength trainer to improve swallowing in inclusion body myositis: A pilot study. Neuromuscular Disorders, 30 (4). pp. 294-300.

Iacoangeli, A., Lin, T., Al Khleifat, A., Jones, A.R., Opie-Martin, S., Coleman, J.R.I., Shatunov, A., Sproviero, W., Williams, K.L., Garton, F., Restuadi, R., Henders, A.K., Mather, K.A., Needham, M., Mathers, S., Nicholson, G., Rowe, D.B., Henderson, R., McCombe, P.A., Pamphlett, R., Blair, I.P., Schultz, D., Sachdev, P.S., Newhouse, S.J., Proitsi, P., Fogh, I., Ngo, S.T., Dobson, R.J.B., Wray, N.R., Steyn, F.J. and Al-Chalabi, A. (2020) Genome-wide Meta-analysis finds the ACSL5-ZDHHC6 locus Is associated with ALS and links weight loss to the disease genetics. Cell Reports, 33 (4). Art. 108323.

Tchan, M., Henderson, R., Kornberg, A., Kairaitis, K., Fuller, M., Davis, M., Ellaway, C., Reardon, K., Corbett, A., Needham, M. and McKelvie, P. (2020) Is it Pompe Disease? Australian diagnostic considerations. Neuromuscular Disorders, 30 (5). P389-P399.

Vucic, S., Ryder, J., Mekhael, L., Henderson, R.D., Mathers, S., Needham, M., Schultz, D.W. and Kiernan, M.C. (2020) Phase 2 randomized placebo controlled double blind study to assess the efficacy and safety of tecfidera in patients with amyotrophic lateral sclerosis (TEALS Study). Medicine, 99 (6). e18904.

Shefner, J.M., Andrews, J.A., Genge, A., Jackson, C., Lechtzin, N., Miller, T.M., Cockroft, B.M., Meng, L., Wei, J., Wolff, A.A., Malik, F.I., Bodkin, C., Brooks, B.R., Caress, J., Dionne, A., Fee, D., Goutman, S.A., Goyal, N.A., Hardiman, O., Hayat, G., Heiman-Patterson, T., Heitzman, D., Henderson, R.D., Johnston, W., Karam, C., Kiernan, M.C., Kolb, S.J., Korngut, L., Ladha, S., Matte, G., Mora, J.S., Needham, M., Oskarsson, B., Pattee, G.L., Pioro, E.P., Pulley, M., Quan, D., Rezania, K., Schellenberg, K.L., Schultz, D., Shoesmith, C., Simmons, Z., Statland, J., Sultan, S., Swenson, A., Berg, L.H.V.D., Vu, T., Vucic, S., Weiss, M., Whyte-Rayson, A., Wymer, J., Zinman, L. and Rudnicki, S.A. (2020) A Phase 2, Double-Blind, randomized, Dose-Ranging trial Of Reldesemtiv in patients with ALS. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration, 22 (3-4). pp. 287-299.

Nabais, M.F., Lin, T., Benyamin, B., Williams, K.L., Garton, F.C., Vinkhuyzen, A.A.E., Zhang, F., Vallerga, C.L., Restuadi, R., Freydenzon, A., Zwamborn, R.A.J., Hop, P.J., Robinson, M.R., Gratten, J., Visscher, P.M., Hannon, E., Mill, J., Brown, M.A., Laing, N.G., Mather, K.A., Sachdev, P.S., Ngoh, S.T., Steyn, F.J., Wallace, L., Henders, A.K., Needham, M., Veldink, J.H., Mathers, S., Nicholson, G., Rowe, D.B., Henderson, R.D., McCombe, P.A., Pamphlett, R., Yang, J., Blair, I.P., McRae, A.F. and Wray, N.R. (2020) Significant out-of-sample classification from methylation profile scoring for amyotrophic lateral sclerosis. Genomic Medicine, 5 (1). Art. 10.

2019

Mohannak, N., Pattison, G., Hird, K. and Needham, M. (2019) Dysphagia in patients with sporadic inclusion body myositis: Management challenges. International Journal of General Medicine, Volume 12 . pp. 465-474.

Paramalingam, S., Counsel, P., Mastaglia, F.L., Keen, H. and Needham, M. (2019) Imaging in the diagnosis of idiopathic inflammatory myopathies; indications and utility. Expert Review of Neurotherapeutics, 19 (2). pp. 173-184.

Regardt, M., Mecoli, C.A., Park, J.K., de Groot, I., Sarver, C., Needham, M., de Visser, M., Shea, B., Bingham, C.O., Lundberg, I.E., Song, Y.W., Christopher-Stine, L. and Alexanderson, H. (2019) OMERACT 2018 Modified Patient-reported outcome domain core set in the life impact area for adult idiopathic inflammatory myopathies. The Journal of Rheumatology, 46 (10). pp. 1351-1354.

Hanna, M.G., Badrising, U.A., Benveniste, O., Lloyd, T.E., Needham, M., Chinoy, H., Aoki, M., Machado, P.M., Liang, C., Reardon, K.A., de Visser, M., Ascherman, D.P., Barohn, R.J., Dimachkie, M.M., Miller, J.A.L., Kissel, J.T., Oskarsson, B., Joyce, N.C., Van den Bergh, P., Baets, J., De Bleecker, J.L., Karam, C., David, W.S., Mirabella, M., Nations, S.P., Jung, H. H., Pegoraro, E., Maggi, L., Rodolico, C., Filosto, M., Shaibani, A.I., Sivakumar, K., Goyal, N.A., Mori-Yoshimura, M., Yamashita, S., Suzuki, N., Katsuno, M., Murata, K., Nodera, H., Nishino, I., Romano, C.D., Williams, V.S.L., Vissing, J., Auberson, L.Z., Wu, M., de Vera, A., Papanicolaou, D.A. and Amato, A.A. (2019) Safety and efficacy of intravenous bimagrumab in inclusion body myositis (RESILIENT): a randomised, double-blind, placebo-controlled phase 2b trial. The Lancet Neurology, 18 (9). pp. 834-844.

Mathew, V., Habib, A., Goyal, N., Goldberg, R., Needham, M. and Mozaffar, T. (2019) Willingness to participate in natural history studies amongst patients with sporadic inclusion body myositis (sIBM): A comparison between the United States and Australia. Neurology, 92 (15S).

2018

Coote, D.J., Davis, M.R., Cabrera, M., Needham, M., Laing, N.G. and Nowak, K.J. (2018) CUGC for Duchenne muscular dystrophy (DMD). European Journal of Human Genetics, 26 (5). pp. 749-757.

Coote, D.J., Davis, M.R., Cabrera, M., Needham, M., Laing, N.G. and Nowak, K.J. (2018) Clinical Utility Gene Card for: Autosomal dominant myotonia congenita (Thomsen Disease). European Journal of Human Genetics, 26 . pp. 1072-1077.

Coote, D., Davis, M.R., Cabrera, M., Needham, M., Laing, N.G. and Nowak, K.J. (2018) Clinical Utility Gene Card for: Becker muscular dystrophy. European Journal of Human Genetics, 26 . pp. 1065-1071.

Regardt, M., Mecoli, C.A., Park, J.K., Needham, M., De Groot, I., Sarver, C., Lundberg, I.E., Shea, B., De Visser, M., Song, Y.W., Bingham, C.O., Christopher-Stine, L. and Alexanderson, H. (2018) A Draft Modified Core Domain Set for Patient-Reported Outcomes (PRO) in Patients with Idiopathic Inflammatory Myopathies (IIM): An Omeract Report. Arthritis and Rheumatalogy, 70 (Suppl 10). Abstract Number: 2913.

Murdoch, J., Needham, M. and Keen, H. (2018) In Patients with Suspected Idiopathic Inflammatory Myopathy, Does Pre-Biopsy Musculoskeletal MRI Result in Greater Yield of Diagnostic Biopsy Results? Summary of Data from a 10-Year Single Hospital Audit. Arthritis and Rheumatalogy, 70 (Suppl 10).

Mecoli, C.A., Park, J.K., Alexanderson, H., Regardt, M., Needham, M., de Groot, I., Sarver, C., Lundberg, I.E., Shea, B., de Visser, M., Song, Y.W., Bingham, C.O. and Christopher-Stine, L. (2018) Perceptions of patients, caregivers, and healthcare providers of idiopathic inflammatory myopathies: An international OMERACT Study. The Journal of Rheumatology, 46 (1). pp. 106-111.

2017

Needham, M. and Mastaglia, F.L. (2017) Advances in inclusion body myositis: genetics, pathogenesis and clinical aspects. Expert Opinion on Orphan Drugs, 5 (5). pp. 431-443.

Dharmadasa, T., Henderson, R.D., Talman, P.S., Macdonell, R.A., Mathers, S., Schultz, D.W., Needham, M., Zoing, M., Vucic, S. and Kiernan, M.C. (2017) Motor neurone disease: progress and challenges. Medical Journal of Australia, 206 (8). pp. 357-362.

Ashton, C. and Needham, M. (2017) Necrotizing Autoimmune Myopathy (NAM). ANCR (Advances in Clinical Neuroscience & Rehabilitation), 16 (4). pp. 5-7.

Callan, A., Capkun, G., Vasanthaprasad, V., Freitas, R. and Needham, M. (2017) A systematic review and meta-analysis of prevalence studies of sporadic inclusion body myositis. Journal of Neuromuscular Diseases, 4 (2). pp. 127-137.

2016

Arunkalaivanan, A., do Nascimento, V.C. and Needham, M. (2016) Cauda equina syndrome: An uncommon cause of urinary retention in a young woman. International Urogynecology Journal, 27 (7). pp. 1121-1123.

Talman, P., Duong, T., Vucic, S., Mathers, S., Venkatesh, S., Henderson, R., Rowe, D., Schultz, D., Edis, R., Needham, M., Macdonnell, R., McCombe, P., Birks, C. and Kiernan, M. (2016) Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort. BMJ Open, 6 (9).

Price, M.A., Barghout, V., Benveniste, O., Christopher-Stine, L., Corbett, A., de Visser, M., Hilton-Jones, D., Kissel, J.T., Lloyd, T.E., Lundberg, I.E., Mastaglia, F., Mozaffar, T., Needham, M., Schmidt, J., Sivakumar, K., DeMuro, C. and Tseng, B.S. (2016) Mortality and causes of death in patients with sporadic inclusion body myositis: Survey study based on the clinical experience of specialists in Australia, Europe and the USA. Journal of Neuromuscular Diseases, 3 (1). pp. 67-75.

Ghaoui, R., Palmio, J., Brewer, J., Lek, M., Needham, M., Evilä, A., Hackman, P., Jonson, P-H, Penttilä, S., Vihola, A., Huovinen, S., Lindfors, M., Davis, R.L., Waddell, L., Kaur, S., Yiannikas, C., North, K., Clarke, N., MacArthur, D.G., Sue, C.M. and Udd, B. (2016) Mutations in HSPB8 causing a new phenotype of distal myopathy and motor neuropathy. Neurology, 86 (4). pp. 391-398.

O'Grady, G.L., Ma, A., Sival, D., Wong, M.T.Y., Peduto, T., Menezes, M.P., Young, H., Waddell, L., Ghaoui, R., Needham, M., Lek, M., North, K.N., MacArthur, D.G., van Ravenswaaij-Arts, C.M.A. and Clarke, N.F. (2016) Prominent scapulae mimicking an inherited myopathy expands the phenotype of CHD7-related disease. European Journal of Human Genetics, 24 (8). pp. 1216-1219.

Gang, Q., Bettencourt, C., Machado, P.M., Brady, S., Holton, J.L., Pittman, A.M., Hughes, D., Healy, E., Parton, M., Hilton-Jones, D., Shieh, P.B., Needham, M., Liang, C., Zanoteli, E., de Camargo, L.V., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Singleton, A.B., Hanna, M.G. and Houlden, H. (2016) Rare variants in SQSTM1 and VCP genes and risk of sporadic inclusion body myositis. Neurobiology of Aging, 47 . e1-e9.

Khade, N., Ashton, C., Davis, M., Knezevic, W and Needham, M. (2016) Severe Neuropathic Pain Syndrome, with Ulceromutilating Neuropathy and Spastic Paraparesis, Associated with the p.Ala354Pro Variant in ATL1. Neurology, 86 (16).

Needham, M. and Mastaglia, F.L. (2016) Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment. Clinical Neurophysiology, 127 (5). pp. 1764-1773.

Ashton, C., Junckerstorff, R.C., Bundell, C., Hollingsworth, P. and Needham, M. (2016) Treatment and outcomes in necrotising autoimmune myopathy: an australian perspective. Neuromuscular Disorders, 26 (11). pp. 734-740.

2015

Lindfors, M., Ghaoui, R., Penttilä, S., Palmio, J., Needham, M., North, K., Clarke, N., Sue, C., Jonson, P., Vihola, A. and Udd, B. (2015) G.P.233: Mutated HSPB8 causes both neurogenic and myopathic disease with muscle proteinopathy. Neuromuscular Disorders, 25 . S256.

Needham, M. and Mastaglia, F.L. (2015) Immunotherapies for Immune-Mediated myopathies: A current perspective. Neurotherapeutics, 13 (1). pp. 132-146.

Mastaglia, F.L. and Needham, M. (2015) Inclusion body myositis: A review of clinical and genetic aspects, diagnostic criteria and therapeutic approaches. Journal of Clinical Neuroscience, 22 (1). pp. 6-13.

van der Stap, D.K.D., Rider, L.G., Alexanderson, H., Huber, A.M., Gualano, B., Gordon, P., van der Net, J., Mathiesen, P., Johnson, L.G., Ernste, F.C., Feldman, B.M., Houghton, K.M., Singh-Grewal, D., Kutzbach, A.G., Munters, L.A., Takken, T., Mastaglia, F.L. and Needham, M. (2015) Proposal for a candidate core set of fitness and strength tests for patients with childhood or adult idiopathic inflammatory myopathies. The Journal of Rheumatology, 43 (1). pp. 169-176.

Gang, Q., Bettencourt, C., Brady, S., Holton, J.L., Pittman, A.M., Hughes, D., Healy, E., Parton, M., Hilton-Jones, D., Shieh, P.B., Needham, M., Liang, C., Zanoteli, E., de Carmargo, L.V., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Singleton, A.B., Hanna, M.G., Houlden, H. and Machado, P.M. (2015) SQSTM1 and VCP mutations in a series of 205 inclusion body myositis cases. In: Muscle Study Group Meeting on Experimental Therapeutics Across the Spectrum of Neuromuscular Disease, 19 - 21 September 2015, Snowbird, UT, USA

Ghaoui, R., Cooper, S.T., Lek, M., Jones, K., Corbett, A., Reddel, S.W., Needham, M., Liang, C., Waddell, L.B., Nicholson, G., O’Grady, G., Kaur, S., Ong, R., Davis, M., Sue, C.M., Laing, N.G., North, K.N., MacArthur, D.G. and Clarke, N.F. (2015) Use of whole-exome sequencing for diagnosis of Limb-Girdle muscular dystrophy. JAMA Neurology, 72 (12). pp. 1424-1432.

Gang, Q., Bettencourt, C., Machado, P.M., Fox, Z., Brady, S., Healy, E., Parton, M., Holton, J.L., Hilton-Jones, D., Shieh, P.B., Zanoteli, E., De Paepe, B., De Bleecker, J., Shaibani, A., Ripolone, M., Violano, R., Moggio, M., Barohn, R.J., Dimachkie, M.M., Mora, M., Mantegazza, R., Zanotti, S., Hanna, M.G., Houlden, H., Needham, M. and Mastaglia, F. (2015) The effects of an intronic polymorphism in TOMM40 and APOE genotypes in sporadic inclusion body myositis. Neurobiology of Aging, 36 (4). 1766.e1-1766.e3.

2014

Ghaoui, R., Corbett, A., Needham, M., MacArthur, D., Sue, C. and Clarke, N. (2014) 19. Diagnosing the limb-girdle muscular dystrophies using whole exome sequencing: An Australian cohort. Journal of Clinical Neuroscience, 21 (11). p. 2039.

Lloyd, T.E., Mammen, A.L., Amato, A.A., Weiss, M.D., Needham, M. and Greenberg, S.A. (2014) Evaluation and construction of diagnostic criteria for inclusion body myositis. Neurology, 83 (5). pp. 426-433.

Ghaoui, R., Corbett, A., Needham, M., Farrar, M., Sampaio, H., Mowat, D., Rajagopalan, S., Liang, C., Kaur, S., Waddell, L., Daly, K., Thomas, B.P., Lek, M., Daly, M.J., North, K.N., MacArthur, D.G., Sue, C.M. and Clarke, N.F. (2014) G.P.219: Diagnosing the limb-girdle muscular dystrophies using whole exome sequencing: An Australian cohort. Neuromuscular Disorders, 24 (9-10). pp. 882-883.

Cabrera, M., Junckerstorff, R., Needham, M., Lamont, P.J. and Laing, N.G. (2014) G.P.51: Clinical and genetic characterization of distal myopathies. Neuromuscular Disorders, 24 (9-10). p. 810.

Rodríguez Cruz, P.M., Needham, M., Hollingsworth, P., Mastaglia, F.L. and Hillman, D.R (2014) G.P.65: Obstructive sleep apnoea and subclinical impairment of respiratory function are common in sporadic inclusion body myositis. Neuromuscular Disorders, 24 (9-10). p. 814.

Geevasinga, N., Cole, C., Herkes, G.K., Barnett, Y., Lin, J. and Needham, M. (2014) Sickle cell disease and posterior reversible leukoencephalopathy. Journal of Clinical Neuroscience, 21 (8). pp. 1329-1332.

Rodríguez Cruz, P.M., Needham, M., Hollingsworth, P., Mastaglia, F.L. and Hillman, D.R. (2014) Sleep disordered breathing and subclinical impairment of respiratory function are common in sporadic inclusion body myositis. Neuromuscular Disorders, 24 (12). pp. 1036-1041.

Needham, M. and Mastaglia, F.L. (2014) Statin myotoxicity: A review of genetic susceptibility factors. Neuromuscular Disorders, 24 (1). pp. 4-15.

2013

Rose, M.R. and Needham, M. (2013) 188th ENMC International Workshop: Inclusion Body Myositis, 2–4 December 2011, Naarden, The Netherlands. Neuromuscular Disorders, 23 (12). pp. 1044-1055.

Rojana-udomsart, A., Mitrpant, C., James, I., Witt, C., Needham, M., Day, T., Kiers, L., Corbett, A., Martinez, P., Wilton, S.D. and Mastaglia, F.L. (2013) Analysis of HLA-DRB3 alleles and supertypical genotypes in the MHC Class II region in sporadic inclusion body myositis. Journal of Neuroimmunology, 254 (1-2). pp. 174-177.

Davis, R.L., Liang, C., Edema-Hildebrand, F., Riley, C., Needham, M. and Sue, C.M. (2013) Fibroblast growth factor 21 is a sensitive biomarker of mitochondrial disease. Neurology, 81 (21). pp. 1819-1826.

Luo, Y-B, Mitrpant, C., Johnsen, R., Fabian, V., Needham, M., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis. International Journal of Clinical and Experimental Pathology, 6 (9). pp. 1723-1733.

Ghaoui, R., Clarke, N., Hollingworth, P. and Needham, M. (2013) Muscle disorders: The latest investigations. Internal Medicine Journal, 43 (9). pp. 970-978.

Derfuss, T., Kalincik, T., Spelman, T., Trojano, M., Duquette, P., Izquierdo, G., Grammond, P., Lugaresi, A., Hupperts, R., Cristiano, E., van Pesch, V., Grand’Maison, F., La Spitaleri, D., Rio, M.E., Flechter, S., Oreja-Guevara, C., Giuliani, G., Savino, A., Amato, M.P., Petersen, T., Fernandez-Bolanos, R., Bergamaschi, R., Iuliano, G., Boz, C., Lechner-Scott, J., Deri, N., Gray, O., Verheul, F., Fiol, M., Barnett, M., van Munster, E., Santiago, V., Moore, F., Slee, M., Saladino, M.L., Alroughani, R., Shaw, C., Kasa, K., Petkovska-Boskova, T., den Braber-Moerland, L., Chapman, J., Skromne, E., Herbert, J., Poehlau, D., Needham, M., Bacile, E.A.B., Arruda, W.O., Paine, M., Singhal, B., Vucic, S., Cabrera-Gomez, J.A. and Butzkueven, H. (2013) Persistence on therapy and propensity matched outcome comparison of two subcutaneous interferon beta 1a dosages for multiple sclerosis. PloS one, 8 (5).

Mastaglia, F.L., Rojana-udomsart, A., James, I., Needham, M., Day, T.J., Kiers, L., Corbett, J.A., Saunders, A.M., Lutz, M.W. and Roses, A.D. (2013) Polymorphism in the TOMM40 gene modifies the risk of developing sporadic inclusion body myositis and the age of onset of symptoms. Neuromuscular Disorders, 23 (12). pp. 969-974.

Luo, Y-B, Johnsen, R.D., Griffiths, L., Needham, M., Fabian, V.A., Fletcher, S., Wilton, S.D. and Mastaglia, F.L. (2013) Primary over-expression of AβPP in muscle does not lead to the development of inclusion body myositis in a new lineage of the MCK-AβPP transgenic mouse. International Journal of Experimental Pathology, 94 (6). pp. 418-425.

Kalincik, T., Vivek, V., Jokubaitis, V.G., Lechner-Scott, J., Trojano, M., Izquierdo, G., Lugaresi, A., Grand'Maison, F., Hupperts, R., Oreja-Guevara, C., Bergamaschi, R., Iuliano, G., Alroughani, R., van Pesch, V., Amato, M.P., Slee, M., Verheul, F., Fernandez-Bolanos, R., Fiol, M., Spitaleri, D., Cristiano, E., Gray, O., Cabrera-Gómez, J.A., Shaygannejad, V., Herbert, J., Vucic, S., Needham, M., Petkovska-Boskova, T., Adella Sirbu, C., Duquette, P., Girard, M., Grammond, P., Boz, C., Giuliani, G., Rio, M., Barnett, M.H., Flechter, S., Moore, F., Singhal, B., Bacie Bacile, E., Saladino, M., Shaw, C., Skromne, E., Vella, N., Spelman, T., Liew, D., Kilpatrick, T. and Butzkueven, H. (2013) Relapse incidence in women and men throughout the course of multiple sclerosis: An MSBase cohort study. In: 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark

Kalincik, T., Vivek, V., Jokubaitis, V., Lechner-Scott, J., Trojano, M., Izquierdo, G., Lugaresi, A., Grand'Maison, F., Hupperts, R., Oreja-Guevara, C., Bergamaschi, R., Iuliano, G., Alroughani, R., van Pesch, V., Amato, M.P., Slee, M., Verheul, F., Fernandez-Bolanos, R., Fiol, M., Spitaleri, D.L., Cristiano, E., Gray, O., Cabrera-Gomez, J.A., Shaygannejad, V., Herbert, J., Vucic, S., Needham, M., Petkovska-Boskova, T., Sirbu, C-A, Duquette, P., Girard, M., Grammond, P., Boz, C., Giuliani, G., Rio, M.E., Barnett, M., Flechter, S., Moore, F., Singhal, B., Bacile, E.A., Saladino, M.L., Shaw, C., Skromne, E., Poehlau, D., Vella, N., Spelman, T., Liew, D., Kilpatrick, T.J. and Butzkueven, H. (2013) Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. Brain, 136 (12). pp. 3609-3617.

Malhotra, A., Reyneke, E. and Needham, M. (2013) Susac's syndrome: An immune mediated endotheliopathy laden with challenges and controversies. BMJ Case Reports, 2013 .

Kalincik, T., Buzzard, K., Trojano, M., Duquette, P., Girard, M., Izquierdo, G., Grammond, P., Lugaresi, A., Petersen, T., Hupperts, R., Bergamaschi, R., Boz, C., Giuliani, G., Barnett, M.H., Lechner-Scott, J., Grand'Maison, F., Oreja-Guevara, C., Iuliano, G., Amato, M.P., Verheul, F., Cristiano, E., Fernandez-Bolanos, R., van Pesch, V., Fiol, M., Rio, M., Slee, M., Flechter, S., Gray, O., Saladino, M., Spitaleri, D., Cabrera-Gómez, J.A., Paine, M., Shaw, C., Alroughani, R., Vella, N., Rózsa, C., Vucic, S., Moore, F., Singhal, B., Deri, N., Needham, M., Santiago, V., Herbert, J., Savino, A., Adella Sirbu, C., Petkovska-Boskova, T., Bacile Bacile, E., Jokubaitis, V.G., Liew, D. and Butzkueven, H. (2013) Symptomatology of multiple sclerosis relapses varies in relation to demographic and clinical factors. In: 29th Congress of the European Committee for Research and Treatment in Multiple Sclerosis (ECTRIMS) 2013, 2 - 5 October 2013, Copenhagen, Denmark

2012

Rojana-udomsart, A., Castley, A., James, I., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Martinez, P., Christiansen, F. and Mastaglia, F.L. (2012) G.P.63 High-resolution analysis of HLA-DRB1 alleles and diplotypes in an Australian inclusion body myositis cohort. Neuromuscular Disorders, 22 (9-10). pp. 853-854.

Rojana-udomsart, A., James, I., Castley, A., Needham, M., Scott, A., Day, T., Kiers, L., Corbett, A., Sue, C., Witt, C., Martinez, P., Christiansen, F. and Mastaglia, F. (2012) High-resolution HLA-DRB1 genotyping in an Australian inclusion body myositis (s-IBM) cohort: An analysis of disease-associated alleles and diplotypes. Journal of Neuroimmunology, 250 (1-2). pp. 77-82.

Scott, A.P., Laing, N.G., Mastaglia, F., Dalakas, M., Needham, M. and Allcock, R.J.N. (2012) Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis. Journal of Neuroimmunology, 250 (1-2). pp. 66-70.

Geevasinga, N., Young, H., Clarke, N., North, K., Sank, K., Tanner, C. and Needham, M. (2012) S.P.55 Transition and outcomes for young men with Duchenne muscular dystrophy in New South Wales. Neuromuscular Disorders, 22 (9-10). pp. 885-886.

Mastaglia, F.L. and Needham, M. (2012) Update on toxic myopathies. Current Neurology and Neuroscience Reports, 12 (1). pp. 54-61.

2011

Kumar, K.R., Liang, C., Needham, M., Burke, D., Sue, C.M. and Ng, K. (2011) Axonal hyperpolarization in inclusion-body myopathy, paget disease of the bone, and frontotemporal dementia (IBMPFD). Muscle & Nerve, 44 (2). pp. 191-196.

Liang, C. and Needham, M. (2011) Necrotizing autoimmune myopathy. Current Opinion in Rheumatology, 23 (6). pp. 612-619.

Scott, A.P., Laing, N.G., Mastaglia, F., Needham, M., Walter, M.C., Dalakas, M.C. and Allcock, R.J.N. (2011) Recombination mapping of the susceptibility region for sporadic inclusion body myositis within the major histocompatibility complex. Journal of Neuroimmunology, 235 (1-2). pp. 77-83.

Rojana-udomsart, A., Needham, M., Luo, Y.B., Fabian, V., Walters, S., Zilko, P.J. and Mastaglia, F.L. (2011) The association of sporadic inclusion body myositis and Sjögren's syndrome in carriers of HLA-DR3 and the 8.1 MHC ancestral haplotype. Clinical Neurology and Neurosurgery, 113 (7). pp. 559-563.

2010

Kumar, K., Liang, C., Needham, M., Burke, D., Sue, C. and Ng, K. (2010) 53. Peripheral axonal hyperpolarisation in Inclusion Body Myopathy, Paget’s disease of the bone and Frontotemporal Dementia (IBMPFD). Journal of Clinical Neuroscience, 17 (12). p. 1626.

Mastaglia, F.L. and Needham, M. (2010) Inclusion Body Myositis. In: Lisak, R.P., Truong, D.D., Carroll, W.M. and Bhidayasiri, R., (eds.) International Neurology. Wiley-Blackwell, pp. 474-476.

Kumar, K.R., Needham, M., Mina, K., Davis, M., Brewer, J., Staples, C., Ng, K., Sue, C.M. and Mastaglia, F.L. (2010) Two Australian families with inclusion-body myopathy, Paget’s disease of bone and frontotemporal dementia: Novel clinical and genetic findings. Neuromuscular Disorders, 20 (5). pp. 330-334.

2009

Needham, M., Scott, A., James, I., Day, T., Kiers, L., Corbett, A., Witt, C., Garlepp, M., Allcock, R., Laing, N., Christiansen, F. and Mastaglia, F. (2009) Epistatic interactions between alleles at the DRB1 locus influence both susceptibility to sIBM and clinical phenotype. In: World Muscle Society Congress, 9 - 12 September 2009, Geneva, Switzerland.

Mastaglia, F.L., Needham, M., Scott, A., James, I., Day, T., Kiers, L., Corbett, A., Witt, C., Garlepp, M., Allcock, R., Laing, N. and Christiansen, F. (2009) G.P.16.09 Epistatic interactions between DRB1 alleles influence susceptibility and clinical phenotype in sporadic inclusion body myositis (sIBM). Neuromuscular Disorders, 19 (8-9). p. 654.

Mastaglia, F.L., Needham, M., Scott, A., James, I., Zilko, P., Day, T., Kiers, L., Corbett, A., Witt, C.S., Allcock, R., Laing, N., Garlepp, M. and Christiansen, F.T. (2009) Sporadic inclusion body myositis: HLA-DRB1 allele interactions influence disease risk and clinical phenotype. Neuromuscular Disorders, 19 (11). pp. 763-765.

2008

Needham, M., Hooper, A., James, I., van Bockxmeer, F., Corbett, A., Day, T., Garlepp, M.J. and Mastaglia, F.L. (2008) Apolipoprotein ε alleles in sporadic inclusion body myositis: A reappraisal. Neuromuscular Disorders, 18 (2). pp. 150-152.

Needham, M., Scott, A., Christiansen, F., James, I., Corbett, A., Day, T., Kiers, L., Laing, N., Allcock, R. and Mastaglia, F.L. (2008) G.P.5.06 HLA alleles and MHC haplotypes in sporadic inclusion body myositis: Frequencies and phenotypic correlations. Neuromuscular Disorders, 18 (9-10). pp. 770-771.

Needham, M., Corbett, A., Day, T., Christiansen, F., Fabian, V. and Mastaglia, F.L. (2008) Prevalence of sporadic inclusion body myositis and factors contributing to delayed diagnosis. Journal of Clinical Neuroscience, 15 (12). pp. 1350-1353.

Needham, M. and Mastaglia, F.L. (2008) Sporadic inclusion body myositis: A continuing puzzle. Neuromuscular Disorders, 18 (1). pp. 6-16.

Needham, M., James, I., Corbett, A., Day, T., Christiansen, F., Phillips, B. and Mastaglia, F.L. (2008) Sporadic inclusion body myositis: Phenotypic variability and influence of HLA-DR3 in a cohort of 57 Australian cases. Journal of Neurology, Neurosurgery & Psychiatry, 79 (9). pp. 1056-1060.

2007

Needham, M., Fabian, V., Knezevic, W., Lamont, P., Panegyres, P., Zilko, P. and Mastaglia, F. (2007) 632: Statins may initiate a persisting immune-mediated myopathy and myositis: A study of 10 cases. Journal of Clinical Neuroscience, 14 (10). p. 1029.

Needham, M., Corbett, A., Day, T. and Mastaglia, F. (2007) G.P.13.06 Sporadic inclusion body myositis (sIBM): A phenotypic spectrum in a cohort of 57 cases. Neuromuscular Disorders, 17 (9-10). p. 850.

Needham, M., Corbett, A., Day, T., Fabian, V. and Mastaglia, F. (2007) G.P.13.07 Prevalence and diagnosis of sporadic inclusion body myositis (sIBM) in Western Australia. Neuromuscular Disorders, 17 (9-10). pp. 850-851.

Scott, A., Laing, N., Mastaglia, F., Needham, M., Walter, M., Dalakas, M. and Allcock, R. (2007) G.P.13.17 Recombinant mapping of MHC susceptibility region in sporadic inclusion body myositis (sIBM). Neuromuscular Disorders, 17 (9-10). pp. 853-854.

Needham, M., Mastaglia, F.L. and Garlepp, M.J. (2007) Genetics of inclusion-body myositis. Muscle & Nerve, 35 (5). pp. 549-561.

Needham, M. and Mastaglia, F.L. (2007) Inclusion body myositis: Current pathogenetic concepts and diagnostic and therapeutic approaches. The Lancet Neurology, 6 (7). pp. 620-631.

Needham, M., Duley, J., Hammond, S., Herkes, G.K., Hirano, M. and Sue, C.M. (2007) Mitochondrial disease mimicking Charcot-Marie Tooth disease. Journal of Neurology, Neurosurgery & Psychiatry, 78 (1). pp. 99-100.

Rowe, D.B., Lewis, V., Needham, M., Rodriguez, M., Boyd, A., McLean, C., Roberts, H., Masters, C.L. and Collins, S.J. (2007) Novel prion protein gene mutation presenting with subacute PSP-like syndrome. Neurology, 68 (11). pp. 868-870.

Needham, M., Fabian, V., Knezevicˇ, W., Panegyres, P., Zilko, P. and Mastaglia, F.L. (2007) Progressive myopathy with up-regulation of MHC-I associated with statin therapy. Neuromuscular Disorders, 17 (2). pp. 194-200.

2006

Meagher, L.J., McKay, D., Herkes, G.K. and Needham, M. (2006) Parkinsonism–hyperpyrexia syndrome: The role of electroconvulsive therapy. Journal of Clinical Neuroscience, 13 (8). pp. 857-859.

2005

Needham, M., Loy, C., MacAnally, L. and Morris, J. (2005) Homolateral imitative synkinesis: A forgotten sign. In: XVIII World Congress of Neurology (WCN) 2005, 5 - 11 November 2005, Sydney, Australia

Meagher, L.J., McKay, D.R. and Needham, M. (2005) Neuroleptic malignant-like syndrome in Parkinson's disease. Australian and New Zealand Journal of Psychiatry, 39 (Supp. 1). A141.

This list was generated on Wed Oct 20 18:44:18 2021 UTC.